Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$27.59 - $66.39 $110,360 - $265,560
-4,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$65.76 - $90.65 $263,040 - $362,600
4,000 New
4,000 $266,000
Q2 2021

Aug 06, 2021

SELL
$57.98 - $96.6 $255,112 - $425,040
-4,400 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$71.56 - $121.23 $314,864 - $533,412
4,400 New
4,400 $330,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.